George J. Olt

Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.

Andrew Berchuck, Ayman H. Kamel, Regina S. Whitaker et al. · PubMed · 1990 · 765 citations

Breast Oncology, Oncology, Medicine +14

Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

David H. Moore, John A. Blessing, Richard P. McQuellon et al. · Journal of Clinical Oncology · 2004 · 634 citations · Full text

Secondary Surgical Cytoreduction for Advanced Ovarian Carcinoma

Peter G. Rose, Stacy Nerenstone, Mark F. Brady et al. · New England Journal of Medicine · 2004 · 399 citations · Full text

Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group

David H. Moore, Gillian Thomas, Gustavo S. Montana et al. · International Journal of Radiation Oncology*Biology*Physics · 1998 · 313 citations

Vulvar Diseases, Gynecological Surgery, Medicine +8

A Phase III Trial of Ifosfamide with or without Cisplatin in Carcinosarcoma of the Uterus: A Gynecologic Oncology Group Study

Gregory P. Sutton, Virginia L. Brunetto, Larry C. Kilgore et al. · Gynecologic Oncology · 2000 · 257 citations

Medicine, Phase Iii Trial, Gynecology +6